Logo image of DNUT

KRISPY KREME INC (DNUT) Stock Fundamental Analysis

USA - NASDAQ:DNUT - US50101L1061 - Common Stock

4.08 USD
+0.16 (+4.08%)
Last: 11/14/2025, 8:00:01 PM
4.0205 USD
-0.06 (-1.46%)
After Hours: 11/14/2025, 8:00:01 PM
Fundamental Rating

1

Taking everything into account, DNUT scores 1 out of 10 in our fundamental rating. DNUT was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. DNUT has a bad profitability rating. Also its financial health evaluation is rather negative. DNUT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year DNUT has reported negative net income.
DNUT had a positive operating cash flow in the past year.
In the past 5 years DNUT reported 4 times negative net income.
DNUT had a positive operating cash flow in each of the past 5 years.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of DNUT (-19.63%) is worse than 93.94% of its industry peers.
DNUT has a Return On Equity of -76.15%. This is in the lower half of the industry: DNUT underperforms 67.42% of its industry peers.
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

Looking at the Gross Margin, with a value of 28.67%, DNUT is doing worse than 78.03% of the companies in the same industry.
DNUT's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DNUT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

0

2. Health

2.1 Basic Checks

DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DNUT has more shares outstanding
The number of shares outstanding for DNUT has been increased compared to 5 years ago.
DNUT has a worse debt/assets ratio than last year.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

DNUT has an Altman-Z score of 0.17. This is a bad value and indicates that DNUT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DNUT (0.17) is worse than 81.06% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that DNUT has dependencies on debt financing.
DNUT has a Debt to Equity ratio (1.35) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACCN/A
WACC7.4%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.36 indicates that DNUT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.36, DNUT is doing worse than 84.85% of the companies in the same industry.
A Quick Ratio of 0.30 indicates that DNUT may have some problems paying its short term obligations.
The Quick ratio of DNUT (0.30) is worse than 84.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.3
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -190.00%.
Looking at the last year, DNUT shows a very negative growth in Revenue. The Revenue has decreased by -10.40% in the last year.
Measured over the past years, DNUT shows a quite strong growth in Revenue. The Revenue has been growing by 11.66% on average per year.
EPS 1Y (TTM)-190%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-10.4%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-1.2%

3.2 Future

Based on estimates for the next years, DNUT will show a very negative growth in Earnings Per Share. The EPS will decrease by -29.84% on average per year.
The Revenue is expected to grow by 3.86% on average over the next years.
EPS Next Y-304%
EPS Next 2Y-71.07%
EPS Next 3Y-30.97%
EPS Next 5Y-29.84%
Revenue Next Year-8.72%
Revenue Next 2Y-4.31%
Revenue Next 3Y-0.63%
Revenue Next 5Y3.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4

0

4. Valuation

4.1 Price/Earnings Ratio

DNUT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DNUT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DNUT is valued a bit more expensive than the industry average as 71.97% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.27
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

DNUT's earnings are expected to decrease with -30.97% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-71.07%
EPS Next 3Y-30.97%

4

5. Dividend

5.1 Amount

DNUT has a Yearly Dividend Yield of 3.57%.
DNUT's Dividend Yield is rather good when compared to the industry average which is at 4.57. DNUT pays more dividend than 89.39% of the companies in the same industry.
DNUT's Dividend Yield is a higher than the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 3.57%

5.2 History

DNUT has been paying a dividend for over 5 years, so it has already some track record.
DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

DNUT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.5%
EPS Next 2Y-71.07%
EPS Next 3Y-30.97%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

KRISPY KREME INC

NASDAQ:DNUT (11/14/2025, 8:00:01 PM)

After market: 4.0205 -0.06 (-1.46%)

4.08

+0.16 (+4.08%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-23 2026-02-23/bmo
Inst Owners43.46%
Inst Owner Change-2.21%
Ins Owners3.6%
Ins Owner Change1.78%
Market Cap698.50M
Revenue(TTM)1.53B
Net Income(TTM)-510.43M
Analysts54.67
Price Target4.27 (4.66%)
Short Float %35.5%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield 3.57%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-3.5%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-23 2025-04-23 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-117.45%
Min EPS beat(2)-353.46%
Max EPS beat(2)118.57%
EPS beat(4)1
Avg EPS beat(4)-81.52%
Min EPS beat(4)-353.46%
Max EPS beat(4)118.57%
EPS beat(8)2
Avg EPS beat(8)-67.78%
EPS beat(12)5
Avg EPS beat(12)-46.53%
EPS beat(16)6
Avg EPS beat(16)-38.2%
Revenue beat(2)0
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-1.53%
Revenue beat(4)0
Avg Revenue beat(4)-3.31%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-1.53%
Revenue beat(8)1
Avg Revenue beat(8)-1.98%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.39%
PT rev (1m)-5.64%
PT rev (3m)-21.34%
EPS NQ rev (1m)-161.82%
EPS NQ rev (3m)-150.92%
EPS NY rev (1m)0%
EPS NY rev (3m)-169.15%
Revenue NQ rev (1m)-0.76%
Revenue NQ rev (3m)-2.96%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF 43.79
P/B 1.04
P/tB N/A
EV/EBITDA 22.27
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)0.09
OCFY2.28%
SpS8.96
BVpS3.92
TBVpS-4.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.63%
ROE -76.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.67%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 12.25
Cap/Depr 83.67%
Cap/Sales 7.48%
Interest Coverage N/A
Cash Conversion 21.56%
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.3
Altman-Z 0.17
F-Score5
WACC7.4%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-190%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y-304%
EPS Next 2Y-71.07%
EPS Next 3Y-30.97%
EPS Next 5Y-29.84%
Revenue 1Y (TTM)-10.4%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-1.2%
Revenue Next Year-8.72%
Revenue Next 2Y-4.31%
Revenue Next 3Y-0.63%
Revenue Next 5Y3.86%
EBIT growth 1Y-1143.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year439.69%
EBIT Next 3Y92.02%
EBIT Next 5YN/A
FCF growth 1Y-709.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.9%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%

KRISPY KREME INC / DNUT FAQ

What is the ChartMill fundamental rating of KRISPY KREME INC (DNUT) stock?

ChartMill assigns a fundamental rating of 1 / 10 to DNUT.


What is the valuation status for DNUT stock?

ChartMill assigns a valuation rating of 0 / 10 to KRISPY KREME INC (DNUT). This can be considered as Overvalued.


Can you provide the profitability details for KRISPY KREME INC?

KRISPY KREME INC (DNUT) has a profitability rating of 1 / 10.


What is the expected EPS growth for KRISPY KREME INC (DNUT) stock?

The Earnings per Share (EPS) of KRISPY KREME INC (DNUT) is expected to decline by -304% in the next year.


How sustainable is the dividend of KRISPY KREME INC (DNUT) stock?

The dividend rating of KRISPY KREME INC (DNUT) is 4 / 10 and the dividend payout ratio is -3.5%.